Skip to main content

stock

ELOX · Eloxx Pharmaceuticals, Inc.

What Eloxx Pharmaceuticals, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live ELOX price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ELOX.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
4,036,459 as of 2026-08-07 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
—
ROA
—

Health

Current ratio
3.7x
Debt/equity
—

Deep value

NCAV
—
NCAV per share
—
Price/NCAV
Locked
NNWC
—
NNWC per share
—
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to —; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30——Gross profit: unreported by this company.-$4.45M-$4.50M
S-1 filed 2026-09-11
2026-03-31——Gross profit: unreported by this company.-$3.79M-$3.75M
S-1 filed 2026-09-11
Assembled from more than one filing; the filing above is only the newest of them.
2025-06-30——Gross profit: unreported by this company.-$1.58M-$1.89M
S-1 filed 2026-09-11
2025-03-31——Gross profit: unreported by this company.-$1.22M-$1.71M
S-1 filed 2026-09-11
Assembled from more than one filing; the filing above is only the newest of them.
2023-12-31——Gross profit: unreported by this company.-$4.03M-$2.89M
S-1 filed 2026-09-11
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2023-09-30——Gross profit: unreported by this company.-$3.64M-$3.59M
10-Q filed 2023-11-13
2023-06-30——Gross profit: unreported by this company.-$4.14M-$4.34M
10-Q filed 2023-11-13
Assembled from more than one filing; the filing above is only the newest of them.
2023-03-31——Gross profit: unreported by this company.-$5.48M-$6.23M
10-Q filed 2023-11-13
Assembled from more than one filing; the filing above is only the newest of them.
Assets
$63.39M
Equity
$46.42M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$0-$6.44M-$6.00M—
2024-12-31$6.36M-$2.47M-$3.14M—
2023-12-31$0-$17.29M-$17.05M—
2022-12-31—-$34.42M-$36.06M-$31.91M
2021-12-31—-$66.02M-$66.73M-$35.09M
2020-12-31—-$33.45M-$34.58M—
2019-12-31—-$50.55M-$50.87M-$39.43M
2018-12-31—-$47.56M-$47.19M-$31.60M
2017-12-31—-$20.39M-$21.21M-$16.17M
2017-06-30—-$2.21M-$933,577—

Company filings

1 offering filing in 12 months

events

  • Results

    Results
    Aug 118-K
  • Unregistered share sale, Shareholder rights changed, Executive or director change, Bylaws or fiscal year change

    Unregistered share saleShareholder rights changedExecutive or director changeBylaws or fiscal year change
    Jun 18-K
  • Shareholder vote results

    Shareholder vote results
    May 18-K

5% owners ()

  • Samsara BioCapital, L.P.

    Passive stake

    9.9%Aug 14SCHEDULE 13G
  • Nantahala Capital Management, LLC

    Passive stake

    9.9%Aug 14SCHEDULE 13G
  • Aberdeen Group plc

    Passive stake

    9.9%Jul 27SCHEDULE 13G
  • Coastlands Capital LP

    Passive stake

    10.0%Jun 17SCHEDULE 13G
  • Domicilium Capital Partners LLC

    Passive stake

    20.0%Jun 17SCHEDULE 13G

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named ELOX, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about ELOX.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about ELOX.

nakagai

Signals on ELOX come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ELOX board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Eloxx Pharmaceuticals, Inc. (ELOX): SEC filings, financials and insider trades · Nakagai